Podcast: Collaborative perseverance to bring change to medicine access
By AmerisourceBergen
Following our panel discussion The EU JCA process: Opportunities and challenges in bringing innovative medicines to patients in Europe, pharmaphorum spoke with Herbert Altmann, Head of Commercialization and Access Solutions Europe, PharmaLex, and Casper Paardekooper, partner at strategic consultancy, Vintura, about the initial expectations for the Joint Clinical Assessment (JCA) framework – including the opportunities and challenges ahead – as well as key learnings from products that went through the pilot phase, and insights into the workings of the JCA process.
Learn more about our end to end suite of commercialization solutions for biopharma companies
Each investment we make is focused on connecting healthcare stakeholders to accelerate healthier futures. Our unrivaled expertise powers us in our vision to help you fully realize your product’s power—through the patients it reaches and the strategic outcomes it delivers.
Topics:
Commercialization
Consulting
Policy
Regulatory
